Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy SubjectsROBERTSON, Sarah M; MALDARELLI, Frank; NATARAJAN, Ven et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 5, pp 513-519, issn 1525-4135, 7 p.Article

Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trialMYLES, P. S; LESLIE, K; ANGLISS, M et al.Anaesthesia. 2004, Vol 59, Num 11, pp 1053-1058, issn 0003-2409, 6 p.Article

Drug eruption and exacerbation of psoriasis related to bupropionGOMEZ-FERNANDEZ, Cristina; HERRANZ PINTO, Pedro; CASADO VERRIER, Beatriz et al.EJD. European journal of dermatology. 2011, Vol 21, Num 1, pp 120-121, issn 1167-1122, 2 p.Article

A Novel, Nonbinary Evaluation of Success and Failure Reveals Bupropion Efficacy Versus Methamphetamine Dependence: Reanalysis of a Multisite TrialMCCANN, David J; LI, Shou-Hua.CNS neuroscience & therapeutics (Print). 2012, Vol 18, Num 5, pp 414-418, issn 1755-5930, 5 p.Article

Effect of bupropion on sexual dysfunctionGINZBURG, Regina; WONG, Yvonne; FADER, Jonathan S et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 12, pp 2096-2099, issn 1060-0280, 4 p.Article

Twenty Percent of a Representative Sample of Patients Taking Bupropion Have Abnormal, Asymptomatic Electroencephalographic FindingsMACALUSO, Matthew; ZACKULA, Rosey; D'EMPAIRE, Inna et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 3, pp 312-317, issn 0271-0749, 6 p.Article

Structures from powders: Bupropion hydrochlorideMACCARONI, Elisabetta; MALPEZZI, Luciana; MASCIOCCHI, Norberto et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 50, Num 2, pp 257-261, issn 0731-7085, 5 p.Article

La conduite du sevrage tabagique = Counselling tobacco withdrawalGUICHENEZ, Philippe; PERRIOT, Jean; DUPONT, Patrick et al.STV. Sang thrombose vaisseaux. 2006, Vol 18, Num 3, pp 136-148, issn 0999-7385, 13 p.Article

An assessment of patient preference and adherence to treatment with Wellbutrin SR : A web-based surveyGRANGER, Arthur L; FEHNEL, Sheri E; HOGUE, Susan L et al.Journal of affective disorders. 2006, Vol 90, Num 2-3, pp 217-221, issn 0165-0327, 5 p.Article

Bupropion in the management of apathyCORCORAN, C; WONG, M. L; O'KEANE, V et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 1, pp 133-135, issn 0269-8811, 3 p.Article

Bupropion in the treatment of problematic online game play in patients with major depressive disorderDOUG HYUN HAN; RENSHAW, Perry F.Journal of psychopharmacology (Oxford). 2012, Vol 26, Num 5, pp 689-696, issn 0269-8811, 8 p.Article

PharmGKB summary: very important pharmacogene information for CYP2B6THORN, Caroline F; LAMBA, Jatinder K; LAMBA, Vishal et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 8, pp 520-523, issn 1744-6872, 4 p.Article

Bupropion metabolism by human placentaXIAOMING WANG; ABDELRAHMAN, Doaa R; ZHARIKOVA, Olga L et al.Biochemical pharmacology. 2010, Vol 79, Num 11, pp 1684-1690, issn 0006-2952, 7 p.Article

Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotineVANN, Robert E; ROSECRANS, John A; JAMES, John R et al.Brain research. 2006, Vol 1117, pp 18-24, issn 0006-8993, 7 p.Article

Outcomes of bupropion therapy for smoking cessation during routine clinical usePALUCK, Elan C; MCCORMACK, James P; ENSOM, Mary H. H et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 2, pp 185-190, issn 1060-0280, 6 p.Article

Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample : An exploratory studyDAVISS, W. Burleson; PEREL, James M; BRENT, David A et al.Therapeutic drug monitoring. 2006, Vol 28, Num 2, pp 190-198, issn 0163-4356, 9 p.Article

Treating nicotine dependenceGLOVER, Elbert D; GLOVER, Penny N; PAYNE, Thomas J et al.The American journal of the medical sciences. 2003, Vol 326, Num 4, pp 183-186, issn 0002-9629, 4 p.Conference Paper

Bupropion : Un bilan allemand = Bupropion: german evaluationLa Revue Prescrire. 2005, Vol 25, Num 260, issn 0247-7750, p. 275Article

Bupropion as an aid to smoking cessation: a review of real-life effectivenessHOLMES, S; ZWAR, N; JIMENEZ-RUIZ, C. A et al.International journal of clinical practice (Esher). 2004, Vol 58, Num 3, pp 285-291, issn 1368-5031, 7 p.Article

Extended treatment with bupropion SR for cigarette smoking cessationKILLEN, Joel D; FORTMANN, Stephen P; MURPHY, Greer M et al.Journal of consulting and clinical psychology. 2006, Vol 74, Num 2, pp 286-294, issn 0022-006X, 9 p.Article

Pharmacological characterisation of the thermogenic effect of bupropionLIU, Yong-Ling; CONNOLEY, Ian P; HEAL, David J et al.European journal of pharmacology. 2004, Vol 498, Num 1-3, pp 219-225, issn 0014-2999, 7 p.Article

The aqueous stability of bupropionO'BYRNE, Paul M; WILLIAMS, Robert; WALSH, John J et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 53, Num 3, pp 376-381, issn 0731-7085, 6 p.Article

Cardiotoxicity associated with accidental bupropion ingestion in a childGIVENS, Melissa L; GABRYSCH, Jeremy.Pediatric emergency care. 2007, Vol 23, Num 4, pp 234-237, issn 0749-5161, 4 p.Article

Steady-state clinical pharmacokinetics of bupropion extended-release in youthsBURLESON DAVISS, W; PEREL, James M; BIRMAHER, Boris et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2006, Vol 45, Num 12, pp 1503-1509, issn 0890-8567, 7 p.Article

Bupropion as an Augmenting Agent in Patients of Depression with Partial ResponseGULREZ, Gaurav; DINESH KUMAR BADYAL; RANDHIR SINGH DESWAL et al.Basic & clinical pharmacology & toxicology (Print). 2012, Vol 110, Num 3, pp 227-230, issn 1742-7835, 4 p.Article